This page is part of the FHIR eMedication exchange formats for the implementation effort of CARA within its EPR community (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Guidance Treatment

Dosage

In reserve

Dosage.asNeededBoolean: used to specify if the medication is “in reserve” (Reservemedikation; médicament en réserve; to be taken by the patient only if the need arises - e.g. pains) or if it’s regular (Grundmedikation; traitement de base/de fond?; to be always taken). By default, the medication is a regular one. If the medication is in reserve, the structured dosage instructions represent the maximum dosage the patient can take.

Route

Site

Medication

Codes

Implementers SHOULD specify a code. Use the GTIN code if available. If it is not (e.g. Colchicine that was not authorized by Swissmedic but still recommended by the Schweizerische Gesellschaft für Rheumatologie), then the relevant ATC code SHOULD be used. The ATC code may be used even if the GTIN is specified. The absence of a code must be exceptional and restricted to borderline cases.

The text may be either:

• a brand/product or
• described as a generic/scientific name or
• a descriptor of a magistral preparation/compound medicine

Ingredients

Implementers SHOULD specify the ingredients of the medication. Active principles SHOULD be flagged with isActive = true. The absence of ingredients must be exceptional and restricted to borderline cases.

Others

form: the galenic form SHOULD be specified.

batch.lotNumber: the lot number MAY be specified by dispensers, if a single lot number (of one or more packages) has been dispensed. It MAY be specified in MedicationStatements or MedicationRequests if a specific lot is to be used (e.g. in controlled trials).

batch.expirationDate: the expiration date MAY be specified by dispensers, if a single expiration date (of one or more packages) has been dispensed.